Investors.hologic.com

More than 1.5 Billion Women Worldwide Lack Essential Health …

WEBHologic Global Women’s Health Index finds widespread barriers to preventive care and a growing gap in women’s well-being between high- and low-income countries More than 1.5 billion women worldwide lack screenings for cancer, heart disease, diabetes or sexually transmitted diseases/infections – even though these conditions …

Actived: 5 days ago

URL: https://investors.hologic.com/press-releases/press-release-details/2022/More-than-1.5-Billion-Women-Worldwide-Lack-Essential-Health-Screenings/default.aspx

Hologic Releases Results of Inaugural Global Women’s Health …

WEBIndex Finds Women’s Health Needs Are Not Being Met Globally and Provides Data Roadmap for Improvement Analysis Identifies Five Health Dimensions that Correlate with Women’s Life Expectancy Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, today shared the findings from its inaugural Hologic Global Women’s Health …

Category:  Health Go Health

Hologic to Showcase Developments in Next-Generation AI …

WEBNew to Hologic’s portfolio of Breast and Skeletal Health Solutions is its Genius AI ® Detection 2.0 solution, a next-generation deep-learning technology designed to improve breast cancer detection while reducing the number of false-positive markings per case. With more than a 70% reduction in false-positive markings per case when …

Category:  Cancer Go Health

Hologic Announces Preliminary Revenue Results for First Quarter …

WEB– Revenue of $1,074.2 Million Exceeds Guidance – – 15.8% Organic Constant Currency Growth in Diagnostics ex-COVID – – 24.5% Organic Constant Currency Growth in Molecular Diagnostics ex-COVID – – 14.7% Organic Constant Currency Growth in Surgical – Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results …

Category:  Health Go Health

Cigna Updates Medical Policy to Cover Hologic’s Acessa® …

WEBNew Coverage Further Validates Laparoscopic Radiofrequency Ablation (Lap-RFA) as a Standard of Care for Uterine Fibroids Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced today that Cigna, one of the largest global health insurance service companies, has updated its medical policy to cover the Acessa® …

Category:  Medical Go Health

Hologic Ranked #1 for Mammography System Performance and …

WEBMARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), an innovative medical technology company primarily focused on improving women’s health, swept the 2022 IMV ServiceTrak™ Awards for Mammography, taking home awards for Best Service, Best Customer Satisfaction and Best System Performance. This is the …

Category:  Medical Go Health

Hologic Announces Financial Results for Fourth Quarter of Fiscal …

WEB– Revenue of $1.317 Billion Exceeds Expectations – – Company Posts GAAP Diluted EPS of $1.28, Non-GAAP Diluted EPS of $1.61 – – Financial Guidance for Fiscal 2022 Anticipates Solid Growth in Core Women’s Health Businesses and Continued Contributions to COVID-19 Fight – Hologic, Inc. (Nasdaq: HOLX) announced today the …

Category:  Health Go Health

Hologic Announces Financial Results for First Quarter of Fiscal 2022

WEBMARLBOROUGH, Mass.-- (BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 25, 2021. “In our first quarter of fiscal 2022, excluding COVID-19, we delivered robust revenue growth across all of our franchises,” said Steve MacMillan, the …

Category:  Health Go Health

Hologic to Webcast Presentation at the Morgan Stanley 16th …

WEBMARLBOROUGH, Mass. , Sept. 6, 2018 / PRNewswire / - Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 16 th Annual Global Healthcare Conference in New York, NY on Friday, September 14 at 11:40 a.m. Eastern Time . The presentation will be webcast live and may be accessed through a link on the …

Category:  Health Go Health

Hologic Announces Financial Results for Third Quarter of Fiscal 2022

WEB– Revenue of $1.003 Billion, GAAP Diluted EPS of $0.90, and Non-GAAP Diluted EPS of $0.95 All Significantly Ahead of Expectations – – Global Organic Molecular Diagnostics ex-COVID-19 Revenue Grows Over 20% in Constant Currency – – Company Again Increases Full-Year Revenue and EPS Guidance – Hologic, Inc. (Nasdaq: HOLX) …

Category:  Health Go Health